Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
Become a Member | Sign in
Home>News>This Article

Navios Flow Cytometer Cleared for Diagnostic Use in US and China

Published: Wednesday, October 02, 2013
Last Updated: Wednesday, October 02, 2013
Bookmark and Share
Beckman has received 510(k) clearance from the US FDA and an Import Medical Device Registration Certificate from the China Food and Drug Administration for in vitro diagnostic use of the system.

In the U.S., the Navios flow cytometer from Beckman Coulter Life Sciences is intended for immunophenotyping in conjunction with proprietary Navios tetra software and CYTO-STAT tetraCHROME reagents.

The Navios has additional capabilities to meet expanded research needs.  It incorporates 12 detectors which include 10 fluorescence detectors and two light scattering detectors.  Simultaneous measurements of integral, peak and width are available for all scatter measurements and up to 10 fluorescent parameters.

Ready to use, pre-optimized CYTO-STAT tetraCHROME reagents make sample preparation easy.  A no-wash protocol reduces sample handling and increases laboratory safety. Beckman Coulter’s Navios tetra system, for simultaneous identification and enumeration of T, B and NK lymphocytes in whole blood, provides an easy-to-use solution for multicolor flow cytometric analysis of lymphocyte subsets as well as CD4+ and CD8+ T cell subsets ratios.

Navios software reports cellular characteristics such as size, granularity and phenotype and combines data in one automated, customized report with plots and formulas.  A variety of reporting options are available.  Easy integration with a variety of automated preparation devices and LIS-readiness offers secure, high-throughput results, even at the highest volumes. 

Mario Koksch, vice president of Beckman Coulter Life Sciences’ Flow Cytometry Business Unit, explained: “Every aspect of the optics design of Navios increases application performance, sensitivity and resolution. These systems enhance flow laboratory efficiency by increasing productivity and improving the reliability and reproducibility of results, thus reducing the cost of flow cytometry testing.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Aquios CL Flow Cytometer Accepted by WHO Prequalification
Fast, compact, fully automated instrument for CD4 monitoring.
Saturday, November 28, 2015
Aquios CL Flow Cytometer Wins Two International Business Awards
The Aquios CL Flow Cytometer delivers first results within 20 minutes.
Tuesday, September 22, 2015
Scientific News
Mathematical Model Forecasts the Path of Breast Cancer
Chances of survival depend on which organs breast cancer tumors colonize first.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Biomedical Imaging at One-Thousandth the Cost
Mathematical modeling enables $100 depth sensor to approximate the measurements of a $100,000 piece of lab equipment.
Improving Outcomes for Lung Cancer and Diabetic Patients
Novel technologies have been developed with support from SBRI Healthcare funding.
New Way of Detecting Cancer
A new RNA test of blood platelets can be used to detect, classify and pinpoint the location of cancer by analysing a sample equivalent to one drop of blood.
Rapid, Portable Ebola Diagnostic
Scientists confirmed the efficiency of the novel Ebola detection method in field trials.
New, Better Test for Prostate Cancer
A study from Karolinska Institutet shows that a new test for prostate cancer is better at detecting aggressive cancer than PSA.
Blood Test Picks Out Prostate Cancer Drug Resistance
Scientists have developed a blood test that can identify key mutations driving resistance to a widely used prostate cancer drug, and identify in advance patients who will not respond to treatment.
Antibody Targets Key Cancer Marker
University of Wisconsin-Madison researchers have created a molecular structure that attaches to a molecule on highly aggressive brain cancer and causes tumors to light up in a scanning machine.
Key Piece of MRSA Vaccine Puzzle
New research funded by the Health Research Board and the Wellcome Trust has pinpointed immune cells that could be targeted by an MRSA vaccine.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos